<SEC-DOCUMENT>0001193125-23-242769-index.html : 20230927 <SEC-HEADER>0001193125-23-242769.hdr.sgml : 20230927 <ACCEPTANCE-DATETIME>20230926214100 ACCESSION NUMBER: 0001193125-23-242769 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20230927 DATE AS OF CHANGE: 20230926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-274421 FILM NUMBER: 231281679 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 </SEC-HEADER> <DOCUMENT> <TYPE>S-1/A <SEQUENCE>1 <FILENAME>d515870ds1a.htm <DESCRIPTION>S-1/A <TEXT> Document 1 - file: d515870ds1a.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>d515870dex11.htm <DESCRIPTION>EX-1.1 <TEXT> Document 2 - file: d515870dex11.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.4 <SEQUENCE>3 <FILENAME>d515870dex44.htm <DESCRIPTION>EX-4.4 <TEXT> Document 3 - file: d515870dex44.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.5 <SEQUENCE>4 <FILENAME>d515870dex45.htm <DESCRIPTION>EX-4.5 <TEXT> Document 4 - file: d515870dex45.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>5 <FILENAME>d515870dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 5 - file: d515870dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>6 <FILENAME>d515870dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 6 - file: d515870dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g515870g07g07.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g515870g07g07.jpg
</DOCUMENT> </SEC-DOCUMENT>